Hadyn Parry is CEO of Oxitec, a company pioneering a new approach using advanced genetics to combat Dengue fever, other insect-borne diseases and agricultural pests.
Hadyn has an extensive background in the Life Science sector. During his fifteen-year career at Zeneca/Syngenta he held various positions, including General Manager of Zeneca Plant Sciences and European Director and Global Head of R&D for Advanta, one of the world’s
largest seed companies. More recently he was CEO of MNL pharmaceuticals, a company that was focused on pioneering a novel approach in immunology.
He is also Chairman of Help for Heroes, a charity founded in 2007 to support wounded British soldiers.